Invokana ketoacidosis (DKA) is a serious and potentially fatal condition. Though diabetic keotacidosis isn’t uncommon in type 1 diabetics, it’s …
Why You Have an Increased Risk of Invokana Kidney Failure
In March 2016, Joan Mullin filed a complaint against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. She claims that Janssen failed …
Invokana Heart Attack: What You Need to Know
Once your blood clots, it can cause a chain reaction leading to an Invokana heart attack. Invokana is an SGLT2 …
Diabetic Ketoacidosis: The Invokana DKA Side Effect
Once diagnosed, type 2 diabetes demands lifestyle changes. Dietary changes. Physical activity changes. You must carefully monitor and regulate blood …
Invokana Complications: Are Patients Made Aware?
Once again, Johnson & Johnson subsidiary Janssen Pharmaceuticals faces scrutiny. Now, it’s for allegedly failing to properly inform patients of …
5,484 Major Invokana Injuries After Two Years on the Market
In March 2013, the FDA approved SGLT2 inhibitor Invokana for treating type 2 diabetes. Since then, the FDA received over …
Over-Medicated: Prescription Drugs in America
Americans take a lot medication. Significantly, Americans take even more prescription drugs every year. In 2013, the Mayo Clinic reported …
Invokana-Related Ketoacidosis: What to Look For
Invokana helps type 2 diabetes patients regulate blood sugar. Invokana lowers A1C (blood sugar measured over a 90-day period). Also …
Invokana and Lower Bone Density: What Patients Need to Know
Invokana (canagliflozin) regulates blood sugar in type 2 diabetes patients. Doctors prescribe Invokana to over 4 million patients in the …
Invokana and Ketoacidosis: Red Flags in the US and Canada
On the heels of the Food and Drug Administration’s safety warning about the use of Invokana and its side effects, Health Canada began its own safety review of the drug.